for predicting the prognosis of chronic lymphocytic leukemia (CLL); malignancy of bone marrow cells; increased reliability, sensitivity and greater quantitative precisiondoi:US7759076 B2An quantitative ZAP-70 assay is provided, with ZAP-70+ and ZAP-70− controls, normal human blood controls, an ...
The duration of psychological morbidity of parents who have lost a child owing to amalignancyis not yet known. From theCambridge English Corpus Anecdotal observations have been made of autoimmune disease remission in patients who have undergone allogeneic bone marrow transplantation as a result of coin...
cancer cell- a cell that is part of a malignant tumor medical specialty,medicine- the branches of medical science that deal with nonsurgical techniques malignant neoplasm,malignant tumor,metastatic tumor- a tumor that is malignant and tends to spread to other parts of the body ...
We evaluated the effect of age on cyclosporine pharmacokinetics in 69 nonobese patients aged 10 months to 56 years (median 22 years) undergoing allogeneic bone marrow transplantation for treatment of aplastic anemia or hematologic malign... GC Yee,TP Lennon,DJ Gmur,... - 《Clinical Pharmacology ...
that malignancy was induced in bone-marrow (leukaemia, malignant myelosclerosis) as well as in bone (osteosarcoma) by radium, especially with large doses. Three case reports of radium intoxication in Britons are noted as compatible with this suggestion, after revised interpretation in two of them...
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic...
Diffuse bone marrow metastasis of cancer cells mimicking hematologic malignancy in a case of rhabdomyosarcoma\ndoi:10.1002/jha2.137Chao〩ung WeiDivision of Hematology, Department of Internal Medicine National Taiwan University Hospital Taipei TaiwanChien〤hin Lin...
CD4+CD56+ malignancy is a rare neoplasm with a typical clinical pattern, an aggressive course and high early relapse rate despite good initial response to chemotherapy. In this review, the impact of different therapeutic approaches on clinical outcome ha
splenomegaly and blood tests showed thrombocytopenia. The patient's history was unremarkable for gastrointestinal disease and she had no risk factors for liver disease. Bone-marrow biopsy showed a hypercellular bone marrow without morphologic features of lymphoma. The patient declined splenectomy at that...
A New Palliative Care Service for Hematologic Malignancies This quality improvement project deals with the important issue of the lack of collaboration between hematologic malignancy–bone marrow transplantation (HM-BMT) units and palliative care (PC) services. Selvaggi and colleagues sought to close this...